Table 1.
Demographic and laboratory data of the Patient Population and their indication for liver transplantation
| Study group (n = 261) | |
| Males/females (n/n), % | (193/68) 73.9%/26.1% |
| Age (yr) | 53.5 ± 9.4 |
| Body mass index (kg/m2) | 26.18 ± 6.40 |
| MELD score | 24 ± 6.5 |
| Indication for liver transplantation (n, %) | |
| Alcoholism | 40 (15.3 %) |
| Viral | 189 (72.4%) |
| Colestatic | 15 (5.7%) |
| Other | 17 (6.5 %) |
| HCC | 107 (41 %) |
| Laboratory data | |
| Hb (g/dL) | 11.3 ± 2.2 (nv:12-16) |
| Hct (%) | 3.4 ± 6.2 (nv: 36-46) |
| PLT (103/μL) | 83.2 ± 66.7 (nv: 150-450) |
| PT (%) | 53.6 ± 22.4 (nv: 70-100) |
| INR | 1.7 ± 0.7 (nv: 0.84-1.24) |
| aPTT ratio | 2.0 ± 9.3 (nv: 0.82-1.24) |
| Fibrinogen (mg/dL) | 190 ± 120 (nv: 200-400) |
| ATIII (%) | 50 ± 27(nv: 80-120) |
Data are expressed as the median ± SD. MELD: Model for end stage liver disease; HCC: Hepatocellular carcinoma; PLT: Platelets; PT: Prothrombin time; INR: International normalized ratio; nv: Normal values.